Hesperidin led to notable decreases in the levels of TNF-α and IL-6 in type 2 diabetes patients, while a hesperidin-derived metabolite suppressed endothelial cell inflammation [93]. The gene discussed is IL6; the disease is type 2 diabetes mellitus.